Edwards Lifesciences Corporation Income (Loss) from Equity Method Investments
Edwards Lifesciences Corporation (EW) reported Income (Loss) from Equity Method Investments of $2.20 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-06.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2013-08-06
- Edwards Lifesciences Corporation income (loss) from equity method investments for the quarter ending 2013-06-30 was $200.00K.
- Edwards Lifesciences Corporation income (loss) from equity method investments for the quarter ending 2013-03-31 was $2.00M, a 185.71% increase year-over-year.
- Edwards Lifesciences Corporation income (loss) from equity method investments for the quarter ending 2012-12-31 was $1.40M, a 16.67% increase year-over-year.
- Edwards Lifesciences Corporation income (loss) from equity method investments for the quarter ending 2012-03-31 was $700.00K.
- Edwards Lifesciences Corporation income (loss) from equity method investments for fiscal 2011 was $700.00K, a 53.33% decline from fiscal 2010.
- Edwards Lifesciences Corporation income (loss) from equity method investments for fiscal 2010 was $1.50M.
- Edwards Lifesciences Corporation income (loss) from equity method investments for fiscal 2009 was -$800.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2013-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $2.20M 10-Q · filed 2013-08-06 | $3.60M derived: sum of 3 quarters · filed 2013-08-06 | ||
| 2013-03-31 | $2.00M 10-Q · filed 2013-05-06 | $3.40M derived: sum of 2 quarters · filed 2013-08-06 | |||
| 2012-12-31 | $1.40M derived: 10-Q 12 month − 10-Q 9 month · filed 2013-08-06 | $1.80M 10-Q · filed 2013-08-06 | |||
| 2012-09-30 | $400.00K 10-Q · filed 2012-11-07 | ||||
| 2012-03-31 | $700.00K 10-Q · filed 2012-05-09 | $1.90M derived: sum of 2 quarters · filed 2013-02-28 | $2.00M derived: sum of 3 quarters · filed 2013-02-28 | $2.30M derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.30M derived: sum of 2 quarters · filed 2013-02-28 | $1.60M derived: sum of 3 quarters · filed 2013-02-28 | $700.00K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $400.00K derived: sum of 2 quarters · filed 2011-11-08 | -$500.00K 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$600.00K 10-Q · filed 2011-08-08 | |||
| 2011-03-31 | -$900.00K 10-Q · filed 2011-05-09 | ||||
| 2010-12-31 | $1.50M 10-K · filed 2012-02-27 | -$1.50M 10-K · filed 2011-02-28 | |||
| 2009-12-31 | -$800.00K 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |